Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)

  1. Schneeweiss, A.
  2. Chia, S.
  3. Hickish, T.
  4. Harvey, V.
  5. Eniu, A.
  6. Hegg, R.
  7. Tausch, C.
  8. Seo, J.H.
  9. Tsai, Y.-F.
  10. Ratnayake, J.
  11. McNally, V.
  12. Ross, G.
  13. Cortés, J.
Revue:
Annals of Oncology

ISSN: 0923-7534,  1569-8041

Année de publication: 2013

Volumen: 24

Número: 9

Pages: 2278-2284

Type: Article

DOI: 10.1093/ANNONC/MDT182 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus